• Explore /
  • Poster
  • / NIVOREN GETUG-AFU 26 translational study: Association of PD-1, AXL, and PBRM-1 with outcomes in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N).

NIVOREN GETUG-AFU 26 translational study: Association of PD-1, AXL, and PBRM-1 with outcomes in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab (N).

Abstract Poster

Authors

null

Yann-Alexandre Vano

Department of Medical Oncology, Georges Pompidou Hospital, University Paris Descartes, Paris, France

Yann-Alexandre Vano , Nathalie Rioux-Leclercq , Cécile Dalban , Catherine Sautes-Fridman , Antoine Bougoüin , Nathalie Chaput , Salem Chouaib , Benoit Beuselinck , Christine Chevreau , Marine Gross-Goupil , Sylvie Negrier , Brigitte Laguerre , Delphine Borchiellini , Irelka Colina-Moreno , Wolf-Herman Fridman , Sylvie Chabaud , Florence Tantot , Janice Barros Monteiro , Bernard Escudier , Laurence Albiges

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 618)

Abstract #

618

Poster Bd #

D4

Abstract Disclosures

Similar Posters

First Author: Jean-Christophe Pignon

First Author: Jose Lutzky

First Author: Miriam Ficial

First Author: Jean-Christophe Pignon